| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 698068 | 77522 | ANAOMI DIARIO 0,1 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ANAOMI DIARIO 0,1 MG/0,02 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 3 x 28 comprimidos | 0,1 mg/0,02 mg | 5 | 84 | 10 | 3 x 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/77522/77522_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/77522/77522_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SHIONOGI S.L.U. | 2013-05-21 | 1 | 1 | 1 | 2013-05-21 | 2013-05-21 | 1 | 2014-01-08 | View Edit Delete | ||||||||||||
| 687623 | 75408 | ANAPEN 0,15 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | ANAPEN 0,15 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA , 1 jeringa precargada de 0,3 ml | 150 microgramos | 33 | 1 | 61 | 1 jeringa precargada de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75408/75408_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75408/75408_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15213 | BIOPROJET PHARMA | 2012-02-07 | 1 | 1 | 1 | 2012-02-07 | 2012-02-07 | 1 | 2016-06-23 | View Edit Delete | ||||||||||||
| 721042 | 75408 | ANAPEN 0,15 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | ANAPEN 0,15 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,3 ml | 150 microgramos | 33 | 2 | 61 | 2 jeringas precargadas de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75408/75408_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75408/75408_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15213 | BIOPROJET PHARMA | 2012-02-07 | 1 | 1 | 1 | 2012-02-07 | 2018-03-14 | 1 | 2020-06-23 | View Edit Delete | ||||||||||||
| 687625 | 75409 | ANAPEN 0,30 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | ANAPEN 0,30 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,3 ml | 300 microgramos | 33 | 1 | 61 | 1 jeringa precargada de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75409/75409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75409/75409_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15213 | BIOPROJET PHARMA | 2012-02-07 | 1 | 1 | 1 | 2012-02-07 | 2012-02-07 | 1 | 2016-06-23 | View Edit Delete | ||||||||||||
| 721057 | 75409 | ANAPEN 0,30 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA | ANAPEN 0,30 mg/0,3 ml SOLUCION INYECTABLE EN JERINGA PRECARGADA, 2 jeringas precargadas de 0,3 ml | 300 microgramos | 33 | 2 | 61 | 2 jeringas precargadas de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/75409/75409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/75409/75409_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15213 | BIOPROJET PHARMA | 2012-02-07 | 1 | 1 | 1 | 2012-02-07 | 2018-03-14 | 1 | 2023-08-01 | View Edit Delete | ||||||||||||
| 722200 | 83253 | ANAPEN 0,50 MG/0,3 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA | ANAPEN 0,50 MG/0,3 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada | 500 microgramos inyectable 0,3 ml | 33 | 1 | 61 | 1 jeringa precargada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/83253/83253_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/83253/83253_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15213 | BIOPROJET PHARMA | 2019-02-20 | 1 | 1 | 1 | 2019-02-20 | 2019-02-20 | 1 | 2020-11-13 | View Edit Delete | ||||||||||||
| 719467 | 82521 | ANARTEX 300 MG/ML SOLUCION ORAL | ANARTEX 300 MG/ML SOLUCION ORAL 1 Frasco de 300 ml | 300 mg/ml | 6 | 300 | 26 | 1 Frasco de 300 ml | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82521/82521_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82521/82521_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2017-10-11 | 1 | 1 | 1 | 2017-10-16 | 2017-10-11 | 1 | 2018-10-30 | Lista II | View Edit Delete | |||||||||||
| 816264 | 63924 | ANASMA 25 MICROGRAMOS/125 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION | ANASMA 25 MICROGRAMOS/125 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 dosis | 25 microgramos/125 microgramos/dosis | 34 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63924/63924_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63924/63924_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-05-24 | 1 | 1 | 1 | 2001-05-24 | 2001-05-24 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 817684 | 63925 | ANASMA 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION | ANASMA 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 dosis | 25 microgramos/250 microgramos/dosis | 34 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63925/63925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63925/63925_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-05-24 | 1 | 1 | 1 | 2001-05-24 | 2001-05-24 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 813089 | 63923 | ANASMA 25 MICROGRAMOS/50 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION | ANASMA 25 MICROGRAMOS/50 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 dosis | 25 microgramos/50 microgramos/dosis | 34 | 120 | 30 | 1 inhalador de 120 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63923/63923_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63923/63923_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 2001-05-24 | 1 | 1 | 1 | 2001-05-24 | 2001-05-24 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 842898 | 62839 | ANASMA ACCUHALER 50 microgramos/100 microgramos/INHALACIÓN, POLVO PARA INHALACIÓN | ANASMA ACCUHALER 50 microgramos/100 microgramos/INHALACIÓN, POLVO PARA INHALACIÓN, 1 inhalador de 60 dosis | 50 microgramos/100 microgramos/dosis | 5 | 60 | 8 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62839/62839_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62839/62839_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1999-12-20 | 1 | 1 | 1 | 1999-12-20 | 1999-12-20 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 700543 | 62840 | ANASMA ACCUHALER 50 microgramos/250 microgramos/INHALACIÓN, POLVO PARA INHALACIÓN | ANASMA ACCUHALER 50 microgramos/250 microgramos/INHALACIÓN, POLVO PARA INHALACIÓN, 1 inhalador de 60 dosis | 50 microgramos/250 microgramos/dosis | 5 | 60 | 8 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62840/62840_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62840/62840_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1999-12-20 | 1 | 1 | 1 | 1999-12-20 | 2015-02-05 | 1 | 2012-01-02 | 842906 | View Edit Delete | |||||||||||
| 700544 | 62841 | ANASMA ACCUHALER 50 microgramos/500 microgramos/INHALACIÓN, POLVO PARA INHALACIÓN | ANASMA ACCUHALER 50 microgramos/500 microgramos/INHALACIÓN, POLVO PARA INHALACIÓN, 1 inhalador de 60 dosis | 50 microgramos/500 microgramos/dosis | 5 | 60 | 8 | 1 inhalador de 60 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62841/62841_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62841/62841_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1999-12-20 | 1 | 1 | 1 | 1999-12-20 | 2015-02-05 | 1 | 2012-01-02 | 843029 | View Edit Delete | |||||||||||
| 662845 | 70472 | ANASTROZOL ACCORD 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL ACCORD 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70472/70472_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70472/70472_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2009-04-21 | 1 | 1 | 1 | 2009-04-21 | 2009-04-21 | 1 | 2011-03-28 | View Edit Delete | ||||||||||||
| 730489 | 85814 | ANASTROZOL AUROVITAS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL AUROVITAS 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 compimidos | 1 mg | 5 | 28 | 10 | 28 compimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85814/85814_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85814/85814_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 38359 | AUROVITAS SPAIN, S.A.U. | 2021-02-26 | 1 | 1 | 1 | 2021-02-27 | 2021-02-26 | 1 | 2022-12-19 | View Edit Delete | ||||||||||||
| 663279 | 69384 | ANASTROZOL CINFA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL CINFA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69384/69384_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69384/69384_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-11-05 | 1 | 1 | 1 | 2007-11-05 | 2010-03-09 | 1 | 2011-10-19 | 660093 | View Edit Delete | |||||||||||
| 680364 | 74032 | ANASTROZOL COMBIX 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL COMBIX 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74032/74032_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74032/74032_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2011-05-13 | 1 | 1 | 1 | 2011-05-13 | 2011-05-13 | 1 | 2012-10-16 | View Edit Delete | ||||||||||||
| 663251 | 69374 | ANASTROZOL KERN PHARMA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL KERN PHARMA 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69374/69374_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69374/69374_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-10-29 | 1 | 1 | 1 | 2013-04-09 | 2013-04-09 | 1 | 2012-01-09 | 660049 | View Edit Delete | |||||||||||
| 665101 | 72152 | ANASTROZOL LIDERFARM 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL LIDERFARM 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72152/72152_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72152/72152_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8730 | FARMALIDER S.A. | 2010-04-26 | 1 | 1 | 1 | 2010-04-26 | 2010-04-26 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 660218 | 69456 | ANASTROZOL NORMON 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ANASTROZOL NORMON 1 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69456/69456_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69456/69456_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-12-04 | 1 | 1 | 1 | 2007-12-04 | 2007-12-04 | 1 | 2011-10-20 | View Edit Delete |
Page 72 of 1036, showing 20 records out of 20703 total, starting on record 1421, ending on 1440